KMD Bioscience specializes in the research and application of VHH, offering a mature recombinant antibody library construction system to provide clients with high-quality natural and immune VHH library development services. The VHH libraries we construct exhibit exceptional diversity and large capacity, with a library size exceeding 1×109 CFU/mL, effectively facilitating clients' research and project development.VHH antibodies consist solely of the variable region of heavy-chain antibodies, featuring a small molecular weight of just 12-15 kDa—significantly lower than that of traditional antibodies and other forms of recombinant antibodies.
With outstanding stability, penetrability, and low immunogenicity, VHH antibodies maintain activity in various environments and can even cross the blood-brain barrier. These properties make them suitable for diverse fields, including medical diagnostics, antibody drug development, and disease treatment. Using camelids such as alpacas as immunization sources, combined with advanced phage display and yeast display technologies, we are committed to providing clients with highly specific and stable VHH antibodies to advance precision medicine and targeted therapy.
Through KMD Bioscience’s VHH platform, clients can obtain high-quality VHH antibodies to meet R&D needs across various fields. We will continue to deepen technological innovation, promote the widespread application of nanobody technology in biomedicine, and support clients in achieving greater breakthroughs in scientific research and commercialization.
General Process
VHH Antibody PlatformGeneral Process
-
Customer Inquiry
-
Plan Confirmation
-
Contract Signing
-
Project Launch
-
Product Delivery
0
